Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Chloroquine can make tumor cells less resistant to chemo/radiotherapy. In this trial
chloroquine is given during radiotherapy. The dose is increased in cohorts of at least 3
patients.